GHDX

Genomic Health, Inc. Press Releases

$26.27
*  
0.76
2.81%
Get GHDX Alerts
*Delayed - data as of Aug. 4, 2015  -  Find a broker to begin trading GHDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GHDX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Urology Practice Publishes Study Showing Oncotype DX® Increases Use of Active Surveillance in Prostate Cancer Patients by 56 Percent
7/30/2015 8:00:00 AM - PR Newswire
▼-1.31 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health to Announce Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4, 2015
7/28/2015 8:00:00 AM - PR Newswire
▲0.73 % Price Change since this news event. The Volume Ratio is 0.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score™ Study
7/14/2015 8:00:00 AM - PR Newswire
▼-2.74 % Price Change since this news event. The Volume Ratio is 1.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Journal of Surgical Oncology Publishes Study Showing Oncotype DX® DCIS Score™ Result Changes Treatment Recommendations in 30 Percent of DCIS Breast Cancer Patients
6/23/2015 8:00:00 AM - PR Newswire
▼-7.11 % Price Change since this news event. The Volume Ratio is 0.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health Presents Positive Proof-of-Concept Data for Bladder Cancer Liquid Biopsy Test
6/16/2015 8:00:00 AM - PR Newswire
▲1.90 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data at AACR Precision Medicine Meeting
6/11/2015 8:00:00 AM - PR Newswire
▼-0.04 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's Leadership in Optimizing Cancer Treatment
6/1/2015 8:00:00 AM - PR Newswire
▼-3.03 % Price Change since this news event. The Volume Ratio is 0.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting Highlight Genomic Health's Leadership in Personalizing Breast, Prostate Cancer Care
5/27/2015 8:00:00 AM - PR Newswire
▼-2.09 % Price Change since this news event. The Volume Ratio is 2.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference
5/27/2015 7:57:00 AM - PR Newswire
▼-2.09 % Price Change since this news event. The Volume Ratio is 2.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on Medicare Coverage for the Oncotype DX® Prostate Cancer Test
5/21/2015 8:00:00 AM - PR Newswire
▼-2.74 % Price Change since this news event. The Volume Ratio is 1.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


UCSF-led Study Shows Oncotype DX® and MRI May Provide Independent Information in Favorable Risk Prostate Cancer
5/20/2015 8:00:00 AM - PR Newswire
▼-2.99 % Price Change since this news event. The Volume Ratio is 1.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health Advances Liquid Biopsy Pipeline, Shows Ability to Accurately Monitor Urine for Presence of Bladder Cancer
5/18/2015 8:00:00 AM - PR Newswire
▼-3.56 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day